| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | microtubule-based process | 3.78e-05 | 1058 | 14 | 6 | GO:0007017 | |
| GeneOntologyBiologicalProcess | M phase | 3.88e-05 | 14 | 14 | 2 | GO:0000279 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle phase | 3.88e-05 | 14 | 14 | 2 | GO:0098762 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 7.87e-05 | 720 | 14 | 5 | GO:0000226 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 1.07e-04 | 23 | 14 | 2 | GO:0090161 | |
| GeneOntologyBiologicalProcess | cell cycle phase | 1.49e-04 | 27 | 14 | 2 | GO:0022403 | |
| GeneOntologyBiologicalProcess | Golgi organization | 1.81e-04 | 168 | 14 | 3 | GO:0007030 | |
| GeneOntologyBiologicalProcess | biological phase | 5.78e-04 | 53 | 14 | 2 | GO:0044848 | |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 1.14e-03 | 316 | 14 | 3 | GO:0140014 | |
| GeneOntologyCellularComponent | microtubule | 3.41e-04 | 533 | 14 | 4 | GO:0005874 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment membrane | 1.31e-03 | 81 | 14 | 2 | GO:0033116 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.44e-03 | 85 | 14 | 2 | GO:0005801 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 2.41e-03 | 899 | 14 | 4 | GO:0099513 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 3.90e-03 | 141 | 14 | 2 | GO:0005793 | |
| GeneOntologyCellularComponent | supramolecular fiber | 6.39e-03 | 1179 | 14 | 4 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 6.54e-03 | 1187 | 14 | 4 | GO:0099081 | |
| GeneOntologyCellularComponent | ciliary basal body | 7.32e-03 | 195 | 14 | 2 | GO:0036064 | |
| GeneOntologyCellularComponent | axoneme | 8.21e-03 | 207 | 14 | 2 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 8.29e-03 | 208 | 14 | 2 | GO:0097014 | |
| Domain | - | 3.54e-04 | 207 | 13 | 3 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 5.00e-04 | 233 | 13 | 3 | IPR011990 | |
| Domain | TPR_1 | 1.73e-03 | 90 | 13 | 2 | PF00515 | |
| Domain | TPR_1 | 1.73e-03 | 90 | 13 | 2 | IPR001440 | |
| Domain | TPR | 3.51e-03 | 129 | 13 | 2 | SM00028 | |
| Domain | TPR_repeat | 3.73e-03 | 133 | 13 | 2 | IPR019734 | |
| Domain | TPR-contain_dom | 4.72e-03 | 150 | 13 | 2 | IPR013026 | |
| Domain | TPR | 5.68e-03 | 165 | 13 | 2 | PS50005 | |
| Domain | TPR_REGION | 5.68e-03 | 165 | 13 | 2 | PS50293 | |
| Pubmed | 1.14e-07 | 23 | 15 | 3 | 22792062 | ||
| Pubmed | 4.09e-06 | 263 | 15 | 4 | 34702444 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 1.82e-05 | 15 | 15 | 2 | 23185636 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.25e-05 | 861 | 15 | 5 | 36931259 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 3.28e-05 | 20 | 15 | 2 | 34128978 | |
| Pubmed | 5.00e-05 | 170 | 15 | 3 | 15057823 | ||
| Pubmed | 6.06e-05 | 27 | 15 | 2 | 35147267 | ||
| Pubmed | 8.33e-05 | 568 | 15 | 4 | 37774976 | ||
| Pubmed | 1.02e-04 | 216 | 15 | 3 | 31519766 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.26e-04 | 232 | 15 | 3 | 25515538 | |
| Pubmed | 1.42e-04 | 242 | 15 | 3 | 34011540 | ||
| Pubmed | 1.58e-04 | 251 | 15 | 3 | 29778605 | ||
| Pubmed | 2.54e-04 | 55 | 15 | 2 | 18448421 | ||
| Pubmed | 2.73e-04 | 57 | 15 | 2 | 29089450 | ||
| Pubmed | 4.01e-04 | 69 | 15 | 2 | 32238831 | ||
| Interaction | RNF43 interactions | 1.05e-05 | 427 | 15 | 5 | int:RNF43 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.25e-04 | 115 | 7 | 2 | 769 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-05 | 186 | 15 | 3 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.35e-05 | 192 | 15 | 3 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.67e-05 | 198 | 15 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.73e-05 | 199 | 15 | 3 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 46 | 15 | 2 | 37ea73d291e35b6865bd3ea4857275a6e5b299d1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 46 | 15 | 2 | 69e9c8cbae3d15bd0823b8c6e48a9d2b9815296b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.00e-04 | 89 | 15 | 2 | eda156a61e7d14087cfdae5e733d6862834fb0e5 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.73e-04 | 124 | 15 | 2 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.49e-04 | 130 | 15 | 2 | c63f402d6ab71c2fcef12174b3139e55a727266c | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.75e-04 | 132 | 15 | 2 | 48449e2e95804a26f204ac7ea763dee26cf794ab | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 9.83e-04 | 140 | 15 | 2 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-03 | 148 | 15 | 2 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-03 | 148 | 15 | 2 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 150 | 15 | 2 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 150 | 15 | 2 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-03 | 151 | 15 | 2 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-03 | 151 | 15 | 2 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 154 | 15 | 2 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 154 | 15 | 2 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 154 | 15 | 2 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-03 | 154 | 15 | 2 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-03 | 155 | 15 | 2 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-03 | 155 | 15 | 2 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.22e-03 | 156 | 15 | 2 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-03 | 156 | 15 | 2 | a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 158 | 15 | 2 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.26e-03 | 159 | 15 | 2 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 162 | 15 | 2 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-03 | 162 | 15 | 2 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 164 | 15 | 2 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 1.38e-03 | 166 | 15 | 2 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-03 | 167 | 15 | 2 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-03 | 167 | 15 | 2 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-03 | 168 | 15 | 2 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-03 | 168 | 15 | 2 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-03 | 168 | 15 | 2 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-03 | 169 | 15 | 2 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.46e-03 | 171 | 15 | 2 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.48e-03 | 172 | 15 | 2 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-03 | 173 | 15 | 2 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.51e-03 | 174 | 15 | 2 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 174 | 15 | 2 | 0cf40ce9d9ad926c4909665aaa224694b5d970cb | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.51e-03 | 174 | 15 | 2 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.53e-03 | 175 | 15 | 2 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-03 | 175 | 15 | 2 | 5f5fc1bf29f07e086951d4f9486b5f07bdcc5d4f | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 1.53e-03 | 175 | 15 | 2 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-03 | 175 | 15 | 2 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-03 | 175 | 15 | 2 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.53e-03 | 175 | 15 | 2 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-03 | 175 | 15 | 2 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-03 | 176 | 15 | 2 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-03 | 177 | 15 | 2 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-03 | 178 | 15 | 2 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-03 | 178 | 15 | 2 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-03 | 178 | 15 | 2 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-03 | 180 | 15 | 2 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.63e-03 | 181 | 15 | 2 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-03 | 181 | 15 | 2 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-03 | 181 | 15 | 2 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.63e-03 | 181 | 15 | 2 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 181 | 15 | 2 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-03 | 182 | 15 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 182 | 15 | 2 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.65e-03 | 182 | 15 | 2 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 182 | 15 | 2 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.65e-03 | 182 | 15 | 2 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-03 | 183 | 15 | 2 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-03 | 183 | 15 | 2 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-club_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-03 | 183 | 15 | 2 | e8e85e5be909f9cd85a6a041190bfcb855dfa1a4 | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-03 | 183 | 15 | 2 | 07cebb0e186e1bff14ac2a6bb6f8412d4aaa2350 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-03 | 184 | 15 | 2 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.69e-03 | 184 | 15 | 2 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-03 | 184 | 15 | 2 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-03 | 184 | 15 | 2 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-03 | 184 | 15 | 2 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.69e-03 | 184 | 15 | 2 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.69e-03 | 184 | 15 | 2 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-03 | 185 | 15 | 2 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.70e-03 | 185 | 15 | 2 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.70e-03 | 185 | 15 | 2 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.70e-03 | 185 | 15 | 2 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-03 | 185 | 15 | 2 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.70e-03 | 185 | 15 | 2 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-03 | 185 | 15 | 2 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-03 | 185 | 15 | 2 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-03 | 185 | 15 | 2 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-03 | 185 | 15 | 2 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 1.70e-03 | 185 | 15 | 2 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-03 | 186 | 15 | 2 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-03 | 186 | 15 | 2 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-03 | 186 | 15 | 2 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-03 | 187 | 15 | 2 | 1399c703505211c510b3f14c7a2aa9930566c473 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.74e-03 | 187 | 15 | 2 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-03 | 187 | 15 | 2 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 1.76e-03 | 188 | 15 | 2 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.76e-03 | 188 | 15 | 2 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-03 | 188 | 15 | 2 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-03 | 188 | 15 | 2 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.76e-03 | 188 | 15 | 2 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-03 | 188 | 15 | 2 | 606907c865bd2f11bb6474932716550f7723d858 | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.75e-06 | 196 | 15 | 4 | 3613_DN | |
| Drug | ethionamide | 1.30e-04 | 26 | 15 | 2 | CID002761171 | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.23e-04 | 185 | 15 | 3 | 1114_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.45e-04 | 191 | 15 | 3 | 993_UP | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.53e-04 | 193 | 15 | 3 | 3242_DN | |
| Drug | 17-AAG; Up 200; 1uM; SKMEL5; HG-U133A | 2.57e-04 | 194 | 15 | 3 | 505_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 5313_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 6234_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 1207_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 1665_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 1243_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 7419_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 2239_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; PC3; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 7491_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 2.69e-04 | 197 | 15 | 3 | 164_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 5410_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A | 2.69e-04 | 197 | 15 | 3 | 1368_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 1148_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 3484_DN | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 7414_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.73e-04 | 198 | 15 | 3 | 914_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 6287_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 6991_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; HL60; HG-U133A | 2.73e-04 | 198 | 15 | 3 | 2005_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; HL60; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 2549_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 4320_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5314_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; HL60; HG-U133A | 2.77e-04 | 199 | 15 | 3 | 2001_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 7401_DN | |
| Drug | Sulmazole [73384-60-8]; Up 200; 14uM; HL60; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 2153_UP | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; HL60; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 6152_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; HL60; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 2533_DN | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; PC3; HT_HG-U133A | 2.81e-04 | 200 | 15 | 3 | 4618_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; PC3; HT_HG-U133A | 2.81e-04 | 200 | 15 | 3 | 6284_DN | |
| Disease | corneal resistance factor | 1.14e-03 | 451 | 14 | 3 | EFO_0010067 | |
| Disease | Thyroid preparation use measurement | 4.62e-03 | 217 | 14 | 2 | EFO_0009933 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EQQWQDLMSIMEMQA | 311 | Q14494 | |
| KMEEMQQHNMSWIEV | 441 | Q9Y4X5 | |
| NEVMEWMNNVMNAQA | 756 | Q92598 | |
| MENLNEMQCMWFQTE | 476 | Q6N069 | |
| MWRQRMQQMSEQVHT | 406 | Q08379 | |
| GMVEKWLQQVEQMML | 1241 | Q8TD57 | |
| REVNQLKQWVTTMMM | 431 | Q494V2 | |
| SNRLEMQWNMTDKMV | 3596 | Q8NDH2 | |
| QEMLMQMREQQSWVI | 916 | Q08AD1 | |
| MIWEQKSTVIAMMTQ | 2296 | Q12923 | |
| KMQIDKNRTMVQQMW | 91 | A4QN01 | |
| MEEWKQQVMTTVQNM | 1221 | Q15643 | |
| TVNQIMMMANNPEDW | 51 | P33981 | |
| NSNCQMEDMTMLWNK | 251 | Q9H2Y7 | |
| MWTFMKENKILDMQQ | 786 | Q9UGR2 |